Immediate Effect of Non-Elastic Taping on Gait Balance in Stroke Patients

Sponsor
Uskudar University (Other)
Overall Status
Completed
CT.gov ID
NCT05940792
Collaborator
(none)
30
1
2
6
5

Study Details

Study Description

Brief Summary

After a stroke, most patients have poor ankle control and difficulty walking. Considering that proper foot placement will provide a more balanced and controlled gait, the aim of this study was to investigate the immediate effect of non-elastic ankle taping providing eversion support on gait balance in stroke patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Nonelastic taping
  • Other: Conservative physiotherapy
N/A

Detailed Description

The study included 30 stroke patients. Participants were randomly assigned to two groups:

intervention group(n=15) and the control group(n=15). The control group received 45 min of conventional physiotherapy. The intervention group received 45 min of conventional physiotherapy after nonelastic taping, which provides eversion support. The gait balance of both groups was evaluated using the Dynamic Gait Index before and after treatment. . Pre- and post-intervention data were statistically analyzed and compared.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Immediate Effect of Non-Elastic Taping on Gait Balance in Stroke Patients: Randomized Controlled Trial
Actual Study Start Date :
Jul 1, 2022
Actual Primary Completion Date :
Oct 15, 2022
Actual Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: intervention group

The intervention group received 45 min of conventional physiotherapy after nonelastic taping, which provides eversion support.

Other: Nonelastic taping
Non-elastic taping was placed on the ankle of the affected side with a plaster band starting from the middle of the sole of the foot and extending from the lateral side of the foot to the level below the knee to provide eversion support.

Active Comparator: control group

The control group received 45 min of conventional physiotherapy

Other: Conservative physiotherapy
The conventional physiotherapy programme included range of motion exercises, balance and gait training and neuromuscular electrical stimulation.

Outcome Measures

Primary Outcome Measures

  1. Dynamic Gait Index (DGI) [5 months]

    The dynamic gait index includes 8 items: walking, walking at different speeds, crossing an obstacle, walking around an obstacle, suddenly turning 180 degrees while walking and stopping, climbing steps, walking by turning the head left and right in the horizontal plane, and walking by turning the head up and down in the vertical plane. The performance of each item was graded with 4 points. The score scale is as follows; 3 independent walking, 2 mild impairment, 1 moderate impairment and 0 severe impairment; the total score that can be obtained varies between 0-24 points. If the total score is between 22and24, it can be said that individuals have safe ambulation, 20-21 points are considered to be a harbinger of fall risk, and scores of 19 or lower have been associated with an increased incidence of falls

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • having a stroke diagnosis at least 6 months ago,

  • being between the ages of 18 and 75,

  • having a spasticity grade of 0, 1, 1+, 2 according to the Modified Ashworth Scale,

  • having no cooperation problems and being mobilized without support.

Exclusion Criteria:
  • orthopedic problems such as surgical intervention, fracture history, presence of cognitive, visual, or cardiovascular diseases

  • skin sensitivity in the foot and ankle that may affect gait.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uskudar University Istanbul Turkey

Sponsors and Collaborators

  • Uskudar University

Investigators

  • Principal Investigator: Beyzanur Dikmen Hoşbaş, Uskudar University
  • Study Chair: Berna Karamancıoglu, Uskudar University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beyzanur Dikmen, Research Assistant, Uskudar University
ClinicalTrials.gov Identifier:
NCT05940792
Other Study ID Numbers:
  • UskudarU1
First Posted:
Jul 11, 2023
Last Update Posted:
Jul 11, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Beyzanur Dikmen, Research Assistant, Uskudar University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2023